Global Healthcare Perspective on AI from HIMSS Vice Chair

Photo: https://www.maxpixel.net/Matrix-Earth-Global-International-Space-Silhouette-2502957 Ahead of HIMSS18, AIMed Magazine had the opportunity to interview Michael Nusbaum, Vice Chair Elect of HIMSS North America Board of Directors (his terms starts July 1, 2018). Michael is the President of M.H. Nusbaum & Associates Ltd., and a global healthcare IT thought leader and expert who has been involved with HIMSS since…

pitch aimed medtech entrepreneur

Making the AI pitch for MedTech entrepreneurs

By David Friedman A pitch has basically one purpose: to get a potential investor to show enough interest and to say, “tell me more” until they write the check. Many entrepreneurs, particularly those in the medical profession are sometimes ill-prepared to make a pitch. They get enamored with a new discovery, process, or technology. Many…

artificial intelligence drug discovery pharma

AI in accelerating drug discovery and development

>>>>REGISTER HERE<<<< DESCRIPTION This breakfast briefing will examine the importance of Artificial Intelligence in accelerating drug development and drug discovery. The speakers will share their succss stories and practical case examples of how they have harnessed machine learning to ‘go faster’ and shorten the development and testing phase from 3-5 years to 1 year. Places…